ni-0401
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2006 (NCT00630643)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
CD3E activator
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109252 ↗
Also known as
- ni-0401
- ni-0401
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00805909 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2007 | NovImmune SA |
| NCT00630643 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2006 | Erasmus University Rotterdam, NovImmune SA |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NovImmune SA | For profit | 2 | 2 | 1 | 2006 |
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1